GlassScriptPhysician profile
Emily K Averill
NPI 1497270771
$2,072.43
in general payments reported to CMS, 2019-2025
18 companies · $643 in 2025
The $643 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $588 · 2022: $315 · 2023: $180 · 2024: $347 · 2025: $643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,169.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $277.36 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $240.69 | 2021-2025 | |
| Biogen, INC. | $226.17 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $201.34 | 2023-2025 | Myfembree |
| Evofem Biosciences, INC. | $162.85 | 2021-2022 | |
| Abbvie INC. | $162.73 | 2021-2023 | |
| Avion Pharmaceuticals | $128.28 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $116.27 | 2021-2025 | |
| Pfizer INC. | $111.03 | 2021-2024 | |
| Exeltis, USA INC. | $94.28 | 2023-2025 | Slynd |
| Myovant Sciences INC. | $74.88 | 2021-2022 | |
| Organon LLC | $65.34 | 2022-2025 | Nexplanon |
| Mylan Pharmaceuticals INC. | $58.40 | 2021-2022 | |
| Therapeuticsmd, INC. | $42.88 | 2021-2022 | |
| Shield Therapeutics INC | $42.14 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $35.79 | 2021 | |
| Hologic Sales and Service, LLC | $17.95 | 2023 | Aptima |
| Pharmacosmos Therapeutics INC. | $14.05 | 2023 | Monoferric |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Averill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.